Asio Capital LLC Makes New $3.42 Million Investment in Regeneron Pharmaceuticals, Inc. $REGN

Asio Capital LLC has initiated a new $3.42 million investment in Regeneron Pharmaceuticals, Inc., acquiring 4,434 shares in the fourth quarter. This comes as other institutional investors have also adjusted their positions in the biopharmaceutical company. Meanwhile, company insiders have sold shares totaling over $2.9 million in the last ninety days, though 7.02% of the stock is still insider-owned.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin